source
- Biogen to acquire RayThera in up to $1 billion deal for immunology pipelineBiogen announced it will acquire RayThera, a startup founded in 2023, in a deal valued at up to $1 billion. The acquisition gives Biogen access to RayThera’s immunology pipeline, which includes th…
- Pfizer CFO Dave Denton to leave; Denali Therapeutics sells $195 million FDA priority review voucherPfizer announced that its chief financial officer Dave Denton will depart on Aug. 15 to take a role outside the pharmaceutical sector. He has been CFO since May 2022. In the interim, finance chief…